Use of Antidepressant Medications and Risk of Fracture in Older Women
β Scribed by Susan J. Diem; Terri L. Blackwell; Katie L. Stone; Jane A. Cauley; Teresa A. Hillier; Elizabeth M. Haney; Kristine E. Ensrud; for the Study of Osteoporotic Fractures Research Group
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 195 KB
- Volume
- 88
- Category
- Article
- ISSN
- 1432-0827
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Many medications used to control blood pressure have been associated with bone metabolism. In addition, hypertension itself may be associated with reduced bone mineral density. We examined the relative risk of fracture among subjects with hypertension initiating singleβdrug therapy for
Prostaglandin inhibition by aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) may inhibit bone loss and preserve hone mineral density (BMD) in vitro and in animal models. The effect of these agents on BMI) and fracture risk in postmenopausal women is unknown. We assessed the risk factors for
## Abstract Fracture risk calculators estimate the absolute risk of osteoporotic fractures. We investigated the performance of the FRAX and Garvan Institute fracture risk calculators in healthy, older, New Zealand, postmenopausal women with normal bone mineral density (BMD) for their age. Fractures
## Abstract We examined if height loss in older women predicts risk of hip fractures, other nonspine fractures, and mortality, and whether this risk is independent of both vertebral fractures (VFx) and bone mineral density (BMD) by dualβenergy Xβray absorptiometry. Among 3124 women age 65 and older